Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yijunkang Probiotic Active Factor Antibacterial Tablets
- Development stage
- Unknown
- Lead developer
- Zhejiang H.Power Pharmaceutical
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Yijunkang (益珺康) Probiotic Active Factor Antibacterial Tablets are an oral probiotic-associated formulation developed and marketed by Zhejiang H.Power Pharmaceutical. The product is characterized by the inclusion of "active factors" derived from probiotics, which are intended to exert antibacterial effects and support the maintenance of a healthy microbiome. Unlike traditional live probiotic supplements, this formulation focuses on the bioactive metabolites or components (active factors) produced by beneficial bacteria. It is positioned within the company's biopharmaceutical and health/wellness segments in China. While the specific bacterial strains used for extraction and the exact molecular composition of the active factors are not publicly detailed, the product is used for general antibacterial support and probiotic-related health maintenance.
- Brand names
- Yijunkang益珺康
- Other names
- 益珺康益生菌活性因子抑菌片Yijunkang-Zhejiang H.Power Pharmaceutical-probiotic-derived antibacterial tabletProbiotic Active Factor Antibacterial Tablets
Beyond the preview
Go deeper on Yijunkang Probiotic Active Factor Antibacterial Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yijunkang Probiotic Active Factor Antibacterial Tablets.